WuXi PharmaTech Earnings: Here’s Why the Stock is Up Now

WuXi PharmaTech (Cayman) Inc. (NYSE:WX) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 0.46%.

WuXi PharmaTech (Cayman) Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share increased 18.75% to $0.38 in the quarter versus EPS of $0.32 in the year-earlier quarter.

Revenue: Rose 15.77% to $125.66 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: WuXi PharmaTech (Cayman) Inc. reported adjusted EPS income of $0.38 per share. By that measure, the company beat the mean analyst estimate of $0.3. It beat the average revenue estimate of $123.71 million.

Quoting Management: “WuXi is succeeding on three fronts: growing, investing to sustain our growth, and returning capital to shareholders,” said Dr. Ge Li, Chairman and Chief Executive Officer. “We achieved strong double-digit revenue growth in the fourth quarter and full year of 2012. We also achieved double-digit growth in earnings per ADS in 2012. We continued to invest to build capabilities and capacity in order to sustain revenue and earnings growth for the long term. While growing and investing, we generated strong free cash flow that allowed us to purchase our shares.”

Key Stats (on next page)…